Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
Assessing the impact of evolving evidence in renal cell carcinoma treatment: an update of the Renal Cell Carcinoma Appropriateness-based Treatment Toolkit (ReCATT)M E Gore, J Bellmunt, T Eisen, et al.
American Journal of Clinical Oncology|August 1, 1996
M-CAVI, a neoadjuvant carboplatin-based regimen for the treatment of T2-4N0M0 carcinoma of the bladderJ Bellmunt, A Ribas, J Albanell, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2012
Evaluation of treatment options for patients with advanced renal cell carcinoma: assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodologyM E Gore, J Bellmunt, T Eisen, et al.
British Journal of Cancer|March 18, 2010
Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patientsC Montagut, M Iglesias, M Arumi, et al.
Anticancer Research|May 15, 1998
p53 oncoprotein as a prognostic indicator in patients with breast cancerR Molina, M A Segui, M A Climent, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancerJ Bellmunt, B J Eigl, E Senkus, et al.
Archivos Espanoles De Urologia|June 1, 1996
[Preliminary results of a phase II randomized controlled trial comparing M-VAC and M-CAVI in patients with bladder cancer (T2-4 N0-1 M0)]J Bellmunt Molins, A Ribas, J Albanell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 21, 2011
Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancerM D Michaelson, J Bellmunt, G R Hudes, et al.
Cancer Metastasis Reviews|August 1, 2015
New advances in genitourinary cancer: evidence gathered in 2014C Suárez, J Puente, E Gallardo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2015
Vinflunine-gemcitabine versus vinflunine-carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomized phase II trial (JASINT1)M De Santis, P J Wiechno, J Bellmunt, et al.
Pageof 13